Ethyl(1S,3S,4S)-4-fluoro-3-hydroxycyclohexane-1-carboxylate, 98%, 1g

5-Amino-1-(4-chlorophenyl)-3-methyl-1H-pyrazole-4-carbonitrile, 95.0%, 10g

1-Boc-3-((Methylamino)methyl)azetidine, 95.0%, 100mg

2-(Trifluoromethoxy)benzyl Bromide>98.0%(GC)5g

L-N-Butylsulfonyl-p-hydroxyphenylalanine, 97.0%, 100g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole, 95+%, 100mg

[2-(2-bromophenoxy)ethyl]dimethylamine, 95.0%, 50mg

1-(Difluoromethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 97%, 25g

1-Cyclohexylpiperidine>98.0%(GC)(T)5mL

3-Bromo-5-(tert-butyl)aniline, 98%, 10g

4-(Boc-4-aminophenyl)butanoic acid, 98.0%, 5g

Cer ICP standard solution, ROTI®Star, 250 ml, HDPE

1H-Indol-3-yl acetate, 95.0%, 1g